Bictegravir/lenacapavir, sold under the brand name Bixlenvo, is a fixed-dose combination antiretroviral medication used for the treatment of HIV/AIDS. It contains bictegravir, a human immunodeficiency virus type 1 (HIV-1) integrase strand transfer inhibitor; and lenacapavir, an HIV-1 capsid inhibitor.
The compounds of every Wikipedia article carrying a Chembox or a Drugbox, refreshed daily, with the values their infoboxes give. The pages need JavaScript; the API does not.